Cytopoint (lokivetmab) is a prescription injectable medication for dogs with itchy skin from allergies. It works by targeting a specific protein (IL-31) involved in the itch signal, rather than suppressing the immune system broadly. A single injection typically controls itch for 4 to 8 weeks. It is not an antibiotic, steroid, or antifungal, and it does not address yeast overgrowth, gut health, or the underlying cause of allergic skin disease. It only requires a veterinary prescription and administration by or under guidance of a veterinarian.
Cytopoint is one of the most searched allergy treatments in veterinary dermatology, and also one of the most misunderstood. This guide answers the questions owners most commonly have: what it is, how it works, whether it is safe, and how it compares to other options.
Cytopoint is administered by injection during a veterinary visit, typically every 4 to 8 weeks as needed.
What Cytopoint Is and What It Treats
Cytopoint is the brand name for lokivetmab, a caninized monoclonal antibody manufactured by Zoetis. It is FDA-approved for the control of itch associated with allergic dermatitis in dogs, including both environmental allergies (atopic dermatitis) and flea allergy dermatitis. It is administered as an injection by a veterinarian, typically in-clinic.
Cytopoint treats the symptom of itch broadly across allergic skin conditions. It is not formulated or indicated for yeast overgrowth specifically, and it does not address gut microbiome imbalance, which is a separate driver of skin and ear symptoms in many dogs alongside or instead of allergies. A dog can have allergic itch, yeast overgrowth, or both simultaneously, and distinguishing between them (or identifying that both are present) is something your veterinarian determines through examination and diagnostic testing such as skin cytology.
How Cytopoint Works
Cytopoint works by binding to and neutralizing interleukin-31 (IL-31), a specific protein (cytokine) that plays a central role in transmitting the itch signal to a dog's nervous system. By targeting this one protein specifically, Cytopoint interrupts the itch sensation without broadly suppressing the immune system the way some other allergy medications do. This targeted mechanism is different from corticosteroids, which have broader anti-inflammatory and immune-suppressing effects across the body.
Think of IL-31 as one specific messenger carrying the "itch" signal. Cytopoint intercepts that one messenger. It does not shut down the broader immune system the way a systemic immunosuppressant would, which is a meaningfully different safety profile than older allergy medications.
How Fast It Works and How Long It Lasts
Most dogs show a noticeable reduction in itching within 1 to 3 days of the injection, and often within 24 hours. This is one of Cytopoint's most cited advantages over daily oral medications, which can take longer to reach full effect. A single injection typically controls itch for 4 to 8 weeks, though the exact duration varies by dog. Some dogs need reinjection at the 4-week mark, others maintain control through the full 8 weeks. Your veterinarian will determine the right reinjection schedule based on how your individual dog responds.
Safety, Side Effects, and the Cancer Question
Cytopoint has been used in veterinary practice since its approval in 2016 and has an extensive safety record. Reported side effects are generally mild and can include injection site reactions, lethargy, vomiting, or diarrhea in a small percentage of dogs. Because it targets a specific protein rather than broadly suppressing the immune system, it does not carry the same class of long-term risks associated with chronic corticosteroid use (such as increased infection risk, liver changes, or Cushing's-like symptoms from prolonged steroid exposure).
This is one of the most frequently searched Cytopoint questions, and it deserves a direct answer: there is no established causal link between Cytopoint and cancer in the published veterinary literature or FDA safety data as of this review. Any medication, over a large enough population of dogs and a long enough time period, will be used in some dogs who are later diagnosed with cancer, which is different from the medication causing it. If you have specific concerns about your dog's cancer risk or a current diagnosis, discuss it directly with your veterinarian, who can review your dog's complete medical history and any relevant research.
Cytopoint is not an immunosuppressant in the broad sense that term is often used (referring to medications like cyclosporine or long-term corticosteroids that suppress the immune system across many pathways). Its targeted mechanism against a single itch-signaling protein is part of why its safety profile differs from broader immune-suppressing allergy treatments. Some owners report increased appetite in their dogs after starting Cytopoint, though this is not among its most commonly documented effects and individual experiences vary. Always report any change you notice to your veterinarian.
Alternatives and How They Compare
Cytopoint is one of several options veterinarians use to manage allergic itch in dogs, each with a different mechanism and use case.
| Option | Type | Onset | Best suited for |
|---|---|---|---|
| Cytopoint | Injectable, targeted (anti-IL-31) | 1 to 3 days | Dogs needing fast, targeted itch control without daily dosing |
| Apoquel (oclacitinib) | Daily oral tablet, JAK inhibitor | Within hours to days | Dogs and owners who prefer or need daily oral dosing |
| Corticosteroids | Oral or injectable, broad immune effect | Fast | Short-term, severe flares; not typically for long-term daily use |
| Cyclosporine (Atopica) | Daily oral, immunosuppressant | 4 to 6 weeks for full effect | Long-term management where a slower-onset option is appropriate |
| Antihistamines (e.g., diphenhydramine, cetirizine) | Daily oral, over the counter | Variable, often mild effect | Mild itch or as an adjunct; generally less effective alone for moderate to severe cases |
Never give your dog any over-the-counter antihistamine or human medication without first confirming the correct product and dose with your veterinarian. Some common human medications and inactive ingredients are unsafe for dogs.
None of the medications above are formulated to address yeast overgrowth specifically. If your dog's itching is driven partly or entirely by yeast (often signaled by a musty, corn-chip-like odor, greasy skin, or symptoms concentrated in ears, paws, and skin folds rather than generalized across the body), a gut-focused approach addressing the underlying microbiome imbalance is a different and complementary layer, not a substitute for your veterinarian's allergy management plan. Skin cytology performed by your vet is the reliable way to determine whether yeast is a contributing factor.
Free Download
The Complete Guide to Ending Your Dog's Yeast Problem
If yeast overgrowth is part of what your vet identifies, this guide covers the gut-first approach that Cytopoint and similar allergy medications are not designed to address.
- The 5-step yeast overgrowth cycle and exactly where it breaks
- A complete 6-layer recovery protocol you can start today
- Honest comparison of every treatment approach and where each falls short on its own
Frequently Asked Questions
Cytopoint is the brand name for lokivetmab, an injectable monoclonal antibody medication that controls itch caused by allergic dermatitis in dogs, including environmental allergies and flea allergy dermatitis. It is prescribed and administered by a veterinarian. It treats the itch symptom of allergic skin disease broadly; it is not specific to yeast overgrowth.
Cytopoint binds to and neutralizes interleukin-31 (IL-31), a specific protein that carries the itch signal to a dog's nervous system. This targeted mechanism interrupts itch without broadly suppressing the immune system the way some other allergy medications do.
Most dogs show reduced itching within 1 to 3 days, often within 24 hours. A single injection typically provides itch control for 4 to 8 weeks, varying by individual dog. Your veterinarian determines the reinjection schedule based on your dog's specific response.
There is no established causal link between Cytopoint and cancer in published veterinary literature or FDA safety data. Cytopoint has an extensive usage history since its 2016 approval. If you have specific concerns about cancer risk, discuss your dog's individual history directly with your veterinarian.
Not in the broad sense the term usually describes. Cytopoint targets one specific protein (IL-31) involved in itch signaling rather than suppressing immune function across many pathways the way corticosteroids or cyclosporine do with long-term use. This targeted mechanism is part of why its safety profile differs from broader immunosuppressive allergy treatments.
Cytopoint has an extensive safety record since its 2016 FDA approval. Reported side effects are generally mild, including injection site reactions, lethargy, or occasional vomiting or diarrhea in a small percentage of dogs. As with any medication, discuss your dog's individual health history with your veterinarian before starting treatment.
Common alternatives include Apoquel (a daily oral tablet), cyclosporine/Atopica (a daily oral immunosuppressant with slower onset), corticosteroids (fast-acting but typically for short-term flares), and antihistamines (milder effect, often used as an adjunct). Each has a different mechanism, onset time, and best-fit use case. Your veterinarian can help determine which fits your dog's specific situation.
No. Cytopoint targets the itch signal from allergic dermatitis broadly; it is not formulated to address yeast overgrowth or the gut microbiome imbalance that often drives it. A dog can have allergic itch, yeast overgrowth, or both at once. Skin cytology performed by your veterinarian is the reliable way to determine whether yeast is contributing to your dog's symptoms, separate from any allergy diagnosis.
Increased appetite is not among Cytopoint's most commonly documented effects, though some owners report noticing it. Individual responses to any medication vary. If you notice appetite changes or any other new symptom after starting Cytopoint, report it to your veterinarian.
If Yeast Is Part of the Picture
YeastGuard supports gut and skin balance with probiotics, prebiotics, and a botanical support blend, working alongside veterinary allergy treatment, not as a replacement for it.
Learn About YeastGuard* These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not a substitute for professional veterinary advice, diagnosis, or treatment. Cytopoint is a prescription medication manufactured by Zoetis; Pawganix has no affiliation with Zoetis. Always seek the advice of your veterinarian with any questions regarding your dog's medical condition or treatment, including Cytopoint. Individual results vary. Pawganix YeastGuard is not intended to diagnose, treat, cure, or prevent any disease and works alongside veterinary care, not instead of it.
